Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
These AI-enabled transcript analysis platforms are designed to transform how legal teams work with deposition content. Enhanced solutions are now available that leverage the power of semantic search, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results